| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CID-5951923 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.04 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.08 | 0.04 |
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.077 | 0.04 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.04 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.04 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.082 | 0.04 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.076 | 0.04 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.04 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.04 |
| mRNA | NVP-ADW742 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.04 |